Welcome!

iPhone Authors: David H Deans, Carmen Gonzalez, Lori MacVittie, Daniel Keeney, Liz McMillan

News Feed Item

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

NEW YORK, Dec. 4, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

http://www.reportlinker.com/p01048443/Global-Sleep-Apnea-Diagnostic--And...

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 68 companies including many key and niche players such as Grass Technologies, Cadwell Laboratories, Inc., CareFusion Corporation, Compumedics Ltd., DeVilbiss Healthcare, Global Medical Holdings LLC, Fisher & Paykel Healthcare Limited, GE Healthcare, Vital Signs Inc., Itamar Medical Ltd., Invacare Corporation, Natus Medical Inc., Bio-Logic, Embla Systems, Inc., Stellate Systems, Inc., Philips Healthcare, ResMed Inc., Teleflex Medical, and Weinmann Geräte für Medizin GmbH+CCo. KG. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Diagnostic Devices I-3Fixed PSG I-3Ambulatory PSG I-3Others (include Screening Devices) I-3Therapeutic Devices I-4CPAP I-4Bi-Level PAP I-4Auto PAP I-4Facial Interfaces (Masks and Humidifiers) I-4II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1

Current & Future Analysis II-1

Prevalence Statistics II-1

The US is the Clear Market Leader, Developing Regions Promise

Growth II-2

Segmental Analysis II-2

2. MARKET DYNAMICS II-3Impact of Economic Recession on the Medical Device Industry II-3Emergence of Dental Sleep Medicine II-3Sleep Apnea/Sleep Disorders in Children Responsible for Obesity II-3Changing Demographics to Play a Major Role II-4Increased Awareness of Comorbid Conditions Spurs Market Growth II-4Demerits of Present Diagnostic Procedures II-4Technology Advancements Improve Patient Compliance II-4Automated CPAP II-5Humidification II-5Patient-Friendly Masks II-5Educational Campaigns II-5Under-Penetration in CPAP Therapy Promises Significant GrowthProspects II-5OSA Industry Witnesses Consistent M&A Activity II-5

3. COMPETITION AND MARKET STRUCTURE II-7

Resmed and Respironics Dominate Competitive Landscape II-7

Table 1: Global Sleep Apnea Market by Leading Players (2011):

Market Share Breakdown for Philips Respironics, Resmed,

Fisher & Paykel, General Electric Vital Signs, and Others

(includes corresponding Graph/Chart) II-7

Table 2: Global Sleep Apnea Diagnostic Systems Market byLeading Players: Market Share Breakdown for CareFusion Corp.,Philips Respironics, Embla Systems, and Others (includescorresponding Graph/Chart) II-7

4. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES - A SYNOPSIS II-8

Significance of Sleep II-8

Stages of Sleep II-8

Sleep Disorders and Stages of Sleep II-8

Sleep Apnea- Introduction II-8

Forms of Apnea II-9

Central Sleep Apnea II-9

Physiological Effects of CSA II-9

Mixed Apnea II-9

Complex Sleep Apnea II-9

Obstructive Sleep Apnea - An Overview II-10

History II-10

Causes of OSA II-10

Symptoms of OSA II-11

Snoring and OSA II-11

Risks and Complications Associated with Untreated Disorder II-11

Risk Groups II-11

Co-Morbid Conditions II-12

Heart Failure II-12

Hypertension II-12

Diabetes II-12

Fatigue II-12

Complications Associated with Surgery and Medications II-12

Financial Implications of Untreated OSA II-13

Pediatric OSA II-13

5. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES II-14OSA Diagnosis II-14Interpreting AHI II-14AHI of 5 to 15: Mild OSA II-14AHI of 15 to 30: Moderate OSA II-14AHI of more than 30: Severe OSA II-14Sleep Apnea Diagnostic Devices II-14Polysomnography (PSG), and Types of Polysomnographs II-14Clinical/Fixed Polysomnographs II-15Ambulatory Polysomnographs II-15Other Sleep Apnea Diagnostic Devices II-16Screening Devices II-16Actigraphs II-16Sleep Apnea Therapeutic Devices II-16Positive Airway Pressure (PAP) Treatment II-16PAP Devices II-16Continuous Positive Airway Pressure (CPAP) Devices II-16Optional Features Available for CPAP Devices II-17Bilevel Positive Airway Pressure (BiPAP) Devices II-17Auto-titrating Positive Airway Pressure (APAP) Devices II-18Facial Interfaces (Masks and Humidifiers) II-18Alternative Apnea Therapies II-18Oral Appliances II-18Surgical Procedures II-19Tracheostomy II-19Uvulo-palato-pharyngoplasty (UPPP) II-19Mandibular Myotomy II-19Laser Assisted Uvuloplasty (LAUP) II-19Somnoplasty or Radio Frequency (RF) Procedure II-19Pillar Palatal Implant System II-20Other Surgical Therapies II-20Over-the-Counter and Pharmacological Therapies II-20Behavioral and Lifestyle Changes II-20

6. RESEARCH FINDINGS II-21

Research Finds Link Between Sleep Apnea and Heart Risks in

Children II-21

Sleep Disorders Increase Risk for Stroke and Blood Pressure

Patients II-21

Individuals with Sleep Apnea Face Greater Risk of Cardiac

Stress During Air Travel II-21

Sleep Apnea Screening Reduces Risk of Post Operative

Complications II-21

7. PRODUCT LAUNCHES/INTRODUCTIONS II-22US Researchers Develop Novel Sleep Apnea Diagnostic DeviceBased on Ultrasonic Sensors II-22NovaSom Introduces MediTrack® II-22ResMed Launches S9 Series for Sleep Apnea Therapy II-22GE Healthcare Launches MARS® Virtual Sleep Lab II-23Remote Analysis Launches iPhone Sleep Diagnostic Application II-23Circadiance Unveils New Zzzephyr Seal II-23Philips Launches New Sleep Therapy System II-24ImThera Medical Unveils aura6000TM Neurostimulation System II-24Philips Unveils Respironics Products in India II-24CardioNet Introduces SomNet Cardiac Indicator II-24FDA Grants 510(K) Clearance to Dormio Tech II-24Ambu Acquires Sleepmate Technologies II-25CIRCADIANTM Enters into Partnership with Sleep PointeTM forProviding OSA Detection and Cure II-25Medtronic Acquires Restore Medical II-25Blackstone to Take Over Apria Healthcare II-25Nihon Kohden Acquires Neurotronics II-25Medtronic Snaps Up Repose GAHM Product Line of InfluENT Medical II-26GE Healthcare Acquires Vital Signs II-26CleveMed Enters into Collaboration with BIDMC Professor II-26Royal Philips Acquires Respironics II-26Cardinal Health Signs Agreement with SleepNet II-27Nihon Kohden Signs New Agreement with Premier II-27

8. RECENT INDUSTRY ACTIVITY II-28

Dehaier Obtains CE Certification for Sleep Diagnostic Devices

and Air Compressors II-28

CareCentrix Takes Over Sleep Management Solutions II-28

Natus Snaps Up Embla Systems II-28

Graymark Acquires Majority Stake in Village Sleep Center II-29

Continucare Expands Operations through Acquisitions II-29

Healthcare of Today to Acquire IMA and SC X-Ray II-29

Cyberonics Invests in ImThera, Acquires Minority Interest II-30

Graymark Healthcare and North Oak Medical Park Form Partnership II-30

Graymark Healthcare Sells Nocturna East Sleep Centers II-31

Watermark Medical Collaborates with AASM for OSA Diagnostic-

Care Study II-31

AZ-TMJ Sets Up Sleep Apnea Treatment Unit II-31

Phyhealth Launches Subsidiary Phyhealth Sleep Care Centre II-31

WideMed Receives CE Certification for Mobile Sleep Apnea System II-32

WideMed Receives Order from GE Healthcare for Morpheus Hx Devices II-32

SleepQuest Buys Extra WatchPAT Devices from Itamar-Medical II-32

Coliseum Northside Hospital Opens Sleep Disorder Center II-32

Naturs Design Signs Partnership with Intus Healthcare II-33

Graymark Healthcare and Coryell Memorial Healthcare Ink Agreement II-33

Compumedics Obtains FDA Approval for GRAEL™ HD-PSG Sllep System II-33

Covidien Sells Sleep Therapy and Bi-level Products to PH Invest II-33

Embla Snaps Up Covidien's Sleep Diagnostic Business II-33

Graymark Healthcare Signs Joint Venture Agreement with

Oklahoma Heart Hospital II-34

Ethicon Takes Over Acclarent II-34

Siix to Develop Sleep Disorders Tracking Device II-34

Blue Shield and Apria Healthcare Ink Agreement Group II-34

Peak Surgical Inks Distribution Agreement with Medtronic II-34

REM Medical, U.S. Health Works Enter into Partnership II-35

Graymark Healthcare Takes Over somniTech and somniCare II-35

ResMed Takes Over Laboratoires Narval II-35

Curative Medical Snaps Up BEVT II-35

Roadside Medical Clinic + Lab Enters into Joint Venture with

Sleep Pointe II-35

Air Liquide Takes Over Comcare Medical II-36

REM Medical Takes Over Tucson Site of PsyPharma Global II-36

Formation of CareFusion II-36

9. FOCUS ON SELECT PLAYERS II-37Grass Technologies (US) II-37Cadwell Laboratories, Inc. (US) II-37CareFusion Corporation (USA) II-37Compumedics Ltd (Australia) II-38DeVilbiss Healthcare (US) II-38Global Medical Holdings LLC (US) II-39Fisher & Paykel Healthcare Limited (New Zealand) II-39GE Healthcare (US) II-39Vital Signs Inc. (US) II-39Itamar Medical Ltd. (Israel) II-40Invacare Corporation (US) II-40Natus Medical Inc. (US) II-40Bio-Logic (US) II-40Embla Systems, Inc. (US) II-41Stellate Systems, Inc. (Canada) II-41Philips Healthcare (USA) II-41ResMed Inc. (US) II-42Teleflex Medical (US) II-42Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) II-42

10. GLOBAL MARKET PERSPECTIVE II-43

Table 3: World Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Geographic

Region - US, Japan, Europe and Rest of World Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2010 through 2018 (includes corresponding Graph/Chart) II-43

Table 4: World Historic Review for Sleep Apnea Diagnostic andTherapeutic Devices by Geographic Region - US, Japan, Europeand Rest of World Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) II-44

Table 5: World 15-Year Perspective for Sleep Apnea Diagnostic

and Therapeutic Devices by Geographic Region - Percentage

Breakdown of Value Sales for US, Japan, Europe and Rest of

World Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) II-45

Table 6: World Recent Past, Current & Future Analysis forSleep Apnea Diagnostic Devices by Geographic Region - US,Japan, Europe and Rest of World Markets Independently Analyzedwith Annual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-46

Table 7: World Historic Review for Sleep Apnea Diagnostic

Devices by Geographic Region - US, Japan, Europe and Rest of

World Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-47

Table 8: World 15-Year Perspective for Sleep Apnea DiagnosticDevices by Geographic Region - Percentage Breakdown of ValueSales for US, Japan, Europe and Rest of World Markets forYears 2004, 2011, and 2018 (includes correspondingGraph/Chart) II-48

Table 9: World Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic Devices by Product Segment -

Clinical/Fixed PSG, Ambulatory PSG, and Other Devices

(Screening Devices) Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-49

Table 10: World Historic Review for Sleep Apnea DiagnosticDevices by Product Segment - Clinical/Fixed PSG, AmbulatoryPSG, and Other Devices (Screening Devices) MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2004 through 2009 (includes corresponding Graph/Chart) II-50

Table 11: World 15-Year Perspective for Sleep Apnea Diagnostic

Devices by Product Segment - Percentage Breakdown of Value

Sales for Clinical/Fixed PSG, Ambulatory PSG, and Other

Devices (Screening Devices) Markets for Years 2004, 2011, and

2018 (includes corresponding Graph/Chart) II-51

Table 12: World Recent Past, Current & Future Analysis forClinical/Fixed PSG Devices by Geographic Region - US, Japan,Europe and Rest of World Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-52

Table 13: World Historic Review for Clinical/Fixed PSG Devices

by Geographic Region - US, Japan, Europe and Rest of World

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-53

Table 14: World 15-Year Perspective for Clinical/Fixed PSGDevices by Geographic Region - Percentage Breakdown of ValueSales for US, Japan, Europe and Rest of World Markets forYears 2004, 2011, and 2018 (includes correspondingGraph/Chart) II-54

Table 15: World Recent Past, Current & Future Analysis for

Ambulatory PSG Devices by Geographic Region - US, Japan,

Europe and Rest of World Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-55

Table 16: World Historic Review for Ambulatory PSG Devices byGeographic Region - US, Japan, Europe and Rest of WorldMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-56

Table 17: World 15-Year Perspective for Ambulatory PSG Devices

by Geographic Region - Percentage Breakdown of Value Sales for

US, Japan, Europe and Rest of World Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) II-57

Table 18: World Recent Past, Current & Future Analysis forOther Diagnostic Devices (Screening Devices) by GeographicRegion - US, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2010 through 2018 (includes corresponding Graph/Chart) II-58

Table 19: World Historic Review for Other Diagnostic Devices

(Screening Devices) by Geographic Region - US, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-59

Table 20: World 15-Year Perspective for Other DiagnosticDevices (Screening Devices) by Geographic Region - PercentageBreakdown of Value Sales for US, Japan, Europe and Rest ofWorld Markets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) II-60

Table 21: World Recent Past, Current & Future Analysis for

Sleep Apnea Therapeutic Devices by Geographic Region - US,

Japan, Europe and Rest of World Markets Independently Analyzed

with Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-61

Table 22: World Historic Review for Sleep Apnea TherapeuticDevices by Geographic Region - US, Japan, Europe and Rest ofWorld Markets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-62

Table 23: World 15-Year Perspective for Sleep Apnea

Therapeutic Devices by Geographic Region - Percentage

Breakdown of Value Sales for US, Japan, Europe and Rest of

World Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) II-63

Table 24: World Recent Past, Current & Future Analysis forSleep Apnea Therapeutic Devices by Product Segment - PAP, AutoPAP, Bi-Level CPAP, and Facial Interfaces (Masks andHumidifiers) Markets Independently Analyzed with Annual Salesin US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-64

Table 25: World Historic Review for Sleep Apnea Therapeutic

Devices by Product Segment - CPAP, Auto PAP, Bi-Level PAP, and

Facial Interfaces (Masks and Humidifiers) Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) II-65

Table 26: World 15-Year Perspective for Sleep ApneaTherapeutic Devices by Product Segment - Percentage Breakdownof Value Sales for CPAP, Auto PAP, Bi-Level PAP, and FacialInterfaces (Masks and Humidifiers) Markets for Years 2004,2011, and 2018 (includes corresponding Graph/Chart) II-66

Table 27: World Recent Past, Current & Future Analysis for

CPAP Devices by Geographic Region - US, Japan, Europe and Rest

of World Markets Independently Analyzed with Annual Sales in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-67

Table 28: World Historic Review for CPAP Devices by GeographicRegion - US, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2004 through 2009 (includes corresponding Graph/Chart) II-68

Table 29: World 15-Year Perspective for CPAP Devices by

Geographic Region - Percentage Breakdown of Value Sales for

US, Japan, Europe and Rest of World Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) II-69

Table 30: World Recent Past, Current & Future Analysis forAuto PAP Devices by Geographic Region - US, Japan, Europe andRest of World Markets Independently Analyzed with Annual Salesin US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-70

Table 31: World Historic Review for Auto PAP Devices by

Geographic Region - US, Japan, Europe and Rest of World

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-71

Table 32: World 15-Year Perspective for Auto PAP Devices byGeographic Region - Percentage Breakdown of Value Sales forUS, Japan, Europe and Rest of World Markets for Years 2004,2011, and 2018 (includes corresponding Graph/Chart) II-72

Table 33: World Recent Past, Current & Future Analysis for

Bi-Level PAP Devices by Geographic Region - US, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-73

Table 34: World Historic Review for Bi-Level PAP Devices byGeographic Region - US, Japan, Europe and Rest of WorldMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-74

Table 35: World 15-Year Perspective for Bi-Level PAP Devices

by Geographic Region - Percentage Breakdown of Value Sales for

US, Japan, Europe and Rest of World Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) II-75

Table 36: World Recent Past, Current & Future Analysis forFacial Interfaces (Masks and Humidifiers) by Geographic Region -US, Japan, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) II-76

Table 37: World Historic Review for Facial Interfaces (Masks

and Humidifiers) by Geographic Region - US, Japan, Europe and

Rest of World Markets Independently Analyzed with Annual Sales

in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-77

Table 38: World 15-Year Perspective for Facial Interfaces(Masks and Humidifiers) by Geographic Region - PercentageBreakdown of Value Sales for US, Japan, Europe and Rest ofWorld Markets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) II-78III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Sleep Disorders: Factsheet III-1

Sleep Apnea in the US: A Demographic Outline III-1

Sleep Apnea Devices: Overview III-1

Sleep Apnea Market Flourishes under the Influence of Myriad

Factors III-2

Home Sleep Testing (HST) III-2

Pricing Trends III-3

Pricing Erosion on the Rise III-3

Premium Products to Command Higher Prices III-3

Reimbursement Scenario III-3

Reimbursement Revisions to Boost OSA Market III-3

Home Sleep Tests Pose Significant Risk for Clinical

Polysomnographs III-4

Reimbursement Criteria for Sleep Apnea Diagnostic and

Therapy Devices III-4

Table 39: Reimbursement Rates of CPAP Devices: 2010 (In

US$) III-5

Average Replacement Schedules III-6

Competitive Landscape III-6

Table 40: US Market for Sleep Therapy (2011) - Percentage

Breakdown of Revenues for Respironics, ResMed, Fisher &

Paykel, and Others III-6

Distribution of Sleep Apnea Devices III-6

A Review of the Sleep Service Providers Market III-7

Greater Awareness Drives More Number of Sleep Labs III-7

Table 41: Increasing Number of Sleep Facilities in the US

(includes corresponding Graph/Chart) III-7

Changeover of the Sleep Lab III-8

Inadequate Sleep Labs - a Bottleneck for Diagnosis of OSA III-8

Inadequate Sleep Labs Surge Development of Portable Sleep

Monitoring III-8

DME Market for Sleep Apnea Devices III-9

Table 42: US Market for CPAP Devices (2010) - Percentage

Breakdown of Value Sales by Durable Medical Equipment (DME)

Suppliers for Apria Healthcare Group, Lincare Holdings Inc,

National Companies and Local Operators (includes

corresponding Graph/Chart) III-9

Strategic Corporate Developments III-9

Focus on Select Players III-13

B.Market Analytics III-18

Table 43: The US Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory

PSG, and Others (Screening Devices)), and Therapeutic

Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces

(Masks and Humidifiers)) Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-18

Table 44: The US Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - DiagnosticDevices (Clinical/Fixed PSG, Ambulatory PSG, and Others(Screening Devices)), and Therapeutic Devices (CPAP ,AutoPAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-19

Table 45: The US 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Diagnostic Devices

(Clinical/ Fixed PSG, Ambulatory PSG, and Others (Screening

Devices)), and Therapeutic Devices (CPAP, Auto PAP,Bi-Level

PAP, and Facial Interfaces (Masks and Humidifiers)) Markets

for Years 2004, 2011, and 2018 (includes corresponding

Graph/Chart) III-20

2. JAPAN III-21A.Market Analysis III-21Japanese Continuous-Positive Airway Pressure (CPAP) Market III-21B.Market Analytics III-22Table 46: Japanese Recent Past, Current & Future Analysisfor Sleep Apnea Diagnostic and Therapeutic Devices byProduct Segment - Diagnostic Devices (Clinical/Fixed PSG,Ambulatory PSG, and Others (Screening Devices)), andTherapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, andFacial Interfaces (Masks and Humidifiers)) MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2010 through 2018 (includes corresponding Graph/Chart) III-22

Table 47: Japanese Historic Review for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and

Others (Screening Devices)), and Therapeutic Devices (CPAP,

Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and

Humidifiers)) Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-23

Table 48: Japanese 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, andOthers (Screening Devices)), and Therapeutic Devices (CPAP,Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets for Years 2004, 2011, and 2018(includes corresponding Graph/Chart) III-24

3. EUROPE III-25

A.Market Analysis III-25

Sleep Apnea Diagnostics - Overview III-25

Trends & Issues III-26

Ambulatory PSGs Gaining over Clinical PSGs III-26

Insufficient Funds & Improper Distribution Endanger Growth

of Sleep Apnea Diagnostics III-26

Strategic Corporate Initiatives III-26

B.Market Analytics III-28

Table 49: European Recent Past, Current & Future Analysis

for Sleep Apnea Diagnostic and Therapeutic Devices by

Geographic Region - France, Germany, Italy, UK, Spain and

Rest of Europe Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-28

Table 50: European Historic Review for Sleep ApneaDiagnostic and Therapeutic Devices by Geographic Region -France, Germany, Italy, UK, Spain and Rest of Europe MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2004 through 2009 (includes corresponding Graph/Chart) III-29

Table 51: European 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Geographic Region -

Percentage Breakdown of Value Sales for France, Germany,

Italy, UK, Spain and Rest of Europe Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) III-30

Table 52: European Recent Past, Current & Future Analysisfor Sleep Apnea Diagnostic and Therapeutic Devices byProduct Segment - Diagnostic Devices (Clinical/Fixed PSG,Ambulatory PSG, and Others (Screening Devices)), andTherapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, andFacial Interfaces (Masks and Humidifiers)) MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2010 through 2018 (includes corresponding Graph/Chart) III-31

Table 53: European Historic Review for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and

Others (Screening Devices)), and Therapeutic Devices (CPAP,

Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and

Humidifiers)) Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-32

Table 54: European 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Diagnostic Devices(Clinical/ Fixed PSG, Ambulatory PSG, and Others (ScreeningDevices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-LevelPAP, and Facial Interfaces (Masks and Humidifiers)) Marketsfor Years 2004, 2011, and 2018 (includes correspondingGraph/Chart) III-33

3a. FRANCE III-34

A.Market Analysis III-34

Outlook III-34

B.Market Analytics III-35

Table 55: French Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea

Therapeutic Devices Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-35

Table 56: French Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-36

Table 57: French 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) III-37

3b. GERMANY III-38A.Market Analysis III-38Weinmann Geräte für Medizin GmbH+CCo. KG - A Key Player III-38B.Market Analytics III-39Table 58: German Recent Past, Current & Future Analysis forSleep Apnea Diagnostic and Therapeutic Devices by ProductSegment - Sleep Apnea Diagnostic Devices and Sleep ApneaTherapeutic Devices Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) III-39

Table 59: German Historic Review for Sleep Apnea Diagnostic

and Therapeutic Devices by Product Segment - Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-40

Table 60: German 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) III-41

3c. ITALY III-42

Market Analysis III-42

Table 61: Italian Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea

Therapeutic Devices Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-42

Table 62: Italian Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-43

Table 63: Italian 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) III-44

3d. THE UNITED KINGDOM III-45A.Market Analysis III-45Sleep Disorder: Factsheet III-45Current and Future Analysis III-45B.Market Analytics III-46Table 64: The UK Recent Past, Current & Future Analysis forSleep Apnea Diagnostic and Therapeutic Devices by ProductSegment - Sleep Apnea Diagnostic Devices and Sleep ApneaTherapeutic Devices Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) III-46

Table 65: The UK Historic Review for Sleep Apnea Diagnostic

and Therapeutic Devices by Product Segment - Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-47

Table 66: The UK 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) III-48

3e. SPAIN III-49

Market Analysis III-49

Table 67: Spanish Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea

Therapeutic Devices Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-49

Table 68: Spanish Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-50

Table 69: Spanish 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) III-51

3f. REST OF EUROPE III-52Market Analysis III-52Table 70: Rest of European Recent Past, Current & FutureAnalysis for Sleep Apnea Diagnostic and Therapeutic Devicesby Product Segment - Sleep Apnea Diagnostic Devices andSleep Apnea Therapeutic Devices Markets IndependentlyAnalyzed with Annual Sales in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-52

Table 71: Rest of European Historic Review for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic

Devices Markets Independently Analyzed with Annual Sales in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-53

Table 72: Rest of European 15-Year Perspective for SleepApnea Diagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) III-54

4. REST OF WORLD III-55

A.Market Analysis III-55

Outlook III-55

Overview of Select Markets III-55

Australia III-55

Significant Demand for Sleep Apnea Therapeutic Devices III-55

Table 73: Australian Sleep Apnea Therapeutic Devices

Market (2011) - Percentage Breakdown of Value Sales for

ResMed, Respironics, Fisher & Paykel and Others (includes

corresponding Graph/Chart) III-56

Distribution III-56

Table 74: Australian Sleep Apnea Therapeutic Devices Market

by Distribution Channel: 2011 (includes corresponding

Graph/Chart) III-56

India - A High Potential Market III-56

Focus on Select Players III-57

B.Market Analytics III-59

Table 75: Rest of World Recent Past, Current & Future

Analysis for Sleep Apnea Diagnostic and Therapeutic Devices

by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,

Ambulatory PSG, and Others (Screening Devices)), and

Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and

Facial Interfaces (Masks and Humidifiers)) Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2010 through 2018 (includes corresponding Graph/Chart) III-59

Table 76: Rest of World Historic Review for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG, andOthers (Screening Devices)), and Therapeutic Devices (CPAP,Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-60

Table 77: Rest of World 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Diagnostic Devices

(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening

Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level

PAP, and Facial Interfaces (Masks and Humidifiers)) Markets

for Years 2004, 2011, and 2018 (includes corresponding

Graph/Chart) III-61

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 68 (including Divisions/Subsidiaries - 106)

The United States (51)Canada (4)Japan (2)Europe (31)- France (4)- Germany (8)- The United Kingdom (5)- Italy (2)- Spain (3)- Rest of Europe (9)Asia-Pacific (Excluding Japan) (13)Latin America (2)Middle East (3)

To order this report:Pathology Industry: Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
The Internet of Things (IoT) is making everything it touches smarter – smart devices, smart cars and smart cities. And lucky us, we’re just beginning to reap the benefits as we work toward a networked society. However, this technology-driven innovation is impacting more than just individuals. The IoT has an environmental impact as well, which brings us to the theme of this month’s #IoTuesday Twitter chat. The ability to remove inefficiencies through connected objects is driving change throughout every sector, including waste management. BigBelly Solar, located just outside of Boston, is trans...
SYS-CON Events announced today that Matrix.org has been named “Silver Sponsor” of Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Matrix is an ambitious new open standard for open, distributed, real-time communication over IP. It defines a new approach for interoperable Instant Messaging and VoIP based on pragmatic HTTP APIs and WebRTC, and provides open source reference implementations to showcase and bootstrap the new standard. Our focus is on simplicity, security, and supporting the fullest feature set.
Predicted by Gartner to add $1.9 trillion to the global economy by 2020, the Internet of Everything (IoE) is based on the idea that devices, systems and services will connect in simple, transparent ways, enabling seamless interactions among devices across brands and sectors. As this vision unfolds, it is clear that no single company can accomplish the level of interoperability required to support the horizontal aspects of the IoE. The AllSeen Alliance, announced in December 2013, was formed with the goal to advance IoE adoption and innovation in the connected home, healthcare, education, aut...
SYS-CON Events announced today that Red Hat, the world's leading provider of open source solutions, will exhibit at Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Red Hat is the world's leading provider of open source software solutions, using a community-powered approach to reliable and high-performing cloud, Linux, middleware, storage and virtualization technologies. Red Hat also offers award-winning support, training, and consulting services. As the connective hub in a global network of enterprises, partners, a...

SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Spansion Inc. (NYSE: CODE), a global leader in embedded systems, today added 96 new products to the Spansion® FM4 Family of flexible microcontrollers (MCUs). Based on the ARM® Cortex®-M4F core, the new MCUs boast a 200 MHz operating frequency and support a diverse set of on-chip peripherals for enhanced human machine interfaces (HMIs) and machine-to-machine (M2M) communications. The rich set of periphera...

The only place to be June 9-11 is Cloud Expo & @ThingsExpo 2015 East at the Javits Center in New York City. Join us there as delegates from all over the world come to listen to and engage with speakers & sponsors from the leading Cloud Computing, IoT & Big Data companies. Cloud Expo & @ThingsExpo are the leading events covering the booming market of Cloud Computing, IoT & Big Data for the enterprise. Speakers from all over the world will be hand-picked for their ability to explore the economic strategies that utility/cloud computing provides. Whether public, private, or in a hybrid form, clo...
Software AG helps organizations transform into Digital Enterprises, so they can differentiate from competitors and better engage customers, partners and employees. Using the Software AG Suite, companies can close the gap between business and IT to create digital systems of differentiation that drive front-line agility. We offer four on-ramps to the Digital Enterprise: alignment through collaborative process analysis; transformation through portfolio management; agility through process automation and integration; and visibility through intelligent business operations and big data.
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace.
Be Among the First 100 to Attend & Receive a Smart Beacon. The Physical Web is an open web project within the Chrome team at Google. Scott Jenson leads a team that is working to leverage the scalability and openness of the web to talk to smart devices. The Physical Web uses bluetooth low energy beacons to broadcast an URL wirelessly using an open protocol. Nearby devices can find all URLs in the room, rank them and let the user pick one from a list. Each device is, in effect, a gateway to a web page. This unlocks entirely new use cases so devices can offer tiny bits of information or simple i...
Things are being built upon cloud foundations to transform organizations. This CEO Power Panel at 15th Cloud Expo, moderated by Roger Strukhoff, Cloud Expo and @ThingsExpo conference chair, will address the big issues involving these technologies and, more important, the results they will achieve. How important are public, private, and hybrid cloud to the enterprise? How does one define Big Data? And how is the IoT tying all this together?
The Internet of Things (IoT) is going to require a new way of thinking and of developing software for speed, security and innovation. This requires IT leaders to balance business as usual while anticipating for the next market and technology trends. Cloud provides the right IT asset portfolio to help today’s IT leaders manage the old and prepare for the new. Today the cloud conversation is evolving from private and public to hybrid. This session will provide use cases and insights to reinforce the value of the network in helping organizations to maximize their company’s cloud experience.
TechCrunch reported that "Berlin-based relayr, maker of the WunderBar, an Internet of Things (IoT) hardware dev kit which resembles a chunky chocolate bar, has closed a $2.3 million seed round, from unnamed U.S. and Switzerland-based investors. The startup had previously raised a €250,000 friend and family round, and had been on track to close a €500,000 seed earlier this year — but received a higher funding offer from a different set of investors, which is the $2.3M round it’s reporting."
The Industrial Internet revolution is now underway, enabled by connected machines and billions of devices that communicate and collaborate. The massive amounts of Big Data requiring real-time analysis is flooding legacy IT systems and giving way to cloud environments that can handle the unpredictable workloads. Yet many barriers remain until we can fully realize the opportunities and benefits from the convergence of machines and devices with Big Data and the cloud, including interoperability, data security and privacy.
All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. Over the summer Gartner released its much anticipated annual Hype Cycle report and the big news is that Internet of Things has now replaced Big Data as the most hyped technology. Indeed, we're hearing more and more about this fascinating new technological paradigm. Every other IT news item seems to be about IoT and its implications on the future of digital busines...
Cultural, regulatory, environmental, political and economic (CREPE) conditions over the past decade are creating cross-industry solution spaces that require processes and technologies from both the Internet of Things (IoT), and Data Management and Analytics (DMA). These solution spaces are evolving into Sensor Analytics Ecosystems (SAE) that represent significant new opportunities for organizations of all types. Public Utilities throughout the world, providing electricity, natural gas and water, are pursuing SmartGrid initiatives that represent one of the more mature examples of SAE. We have s...
The Internet of Things needs an entirely new security model, or does it? Can we save some old and tested controls for the latest emerging and different technology environments? In his session at Internet of @ThingsExpo, Davi Ottenheimer, EMC Senior Director of Trust, will review hands-on lessons with IoT devices and reveal privacy options and a new risk balance you might not expect.
IoT is still a vague buzzword for many people. In his session at Internet of @ThingsExpo, Mike Kavis, Vice President & Principal Cloud Architect at Cloud Technology Partners, will discuss the business value of IoT that goes far beyond the general public's perception that IoT is all about wearables and home consumer services. The presentation will also discuss how IoT is perceived by investors and how venture capitalist access this space. Other topics to discuss are barriers to success, what is new, what is old, and what the future may hold.
Swiss innovators dizmo Inc. launches its ground-breaking software, which turns any digital surface into an immersive platform. The dizmo platform seamlessly connects digital and physical objects in the home and at the workplace. Dizmo breaks down traditional boundaries between device, operating systems, apps and software, transforming the way users work, play and live. It supports orchestration and collaboration in an unparalleled way enabling any data to instantaneously be accessed on any surface, anywhere and made interactive. Dizmo brings fantasies as seen in Sci-fi movies such as Iro...
There’s Big Data, then there’s really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at 6th Big Data Expo®, Hannah Smalltree, Director at Treasure Data, to discuss how IoT, Big Data and deployments are processing massive data volumes from wearables, utilities and other mach...
This Internet of Nouns trend is still in the early stages and many of our already connected gadgets do provide human benefits over the typical infotainment. Internet of Things or IoT. You know, where everyday objects have software, chips, and sensors to capture data and report back. Household items like refrigerators, toilets and thermostats along with clothing, cars and soon, the entire home will be connected. Many of these devices provide actionable data - or just fun entertainment - so people can make decisions about whatever is being monitored. It can also help save lives.